Delivery Order SPE2DB22D2009-SPE2DB25FL8HW
Award Date 3/18/25
Potential Completion Date 3/19/25
Potential Value $1.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $1,522.96 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide VYVANSE 70 MG CAPSULE 100S. The contract has an ultimate completion date of June 11, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which serves as a comprehensive global pharmaceutical support vehicle with a...
- This is a $1,862.11 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVANSE 70 MG CAPSULE 100S, a prescription medication. The contract has an ultimate completion date of April 15, 2025 and was awarded on April 14, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
- This is a $15,212.33 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VYVANSE 50 MG CAPSULE 100S, a medication, with a period of performance ending on March 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This is a $1,189.34 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VYVANSE 30 MG CAPSULE 100S, a prescription medication, with a performance period extending through June 10, 2025. This delivery order is not set aside and represents open competition. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,801.92, is for the delivery of VYVANSE 60 MG CAPSULE 100S, a medication. The contract has a firm fixed price pricing type and a completion date of January 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $13,780.61 firm fixed-price contract is for the delivery of 4,567,612,803 units of the prescription medication VYVANSE 30 MG CAPSULE 100S. The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a $1,228.38 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VYVANSE 30 MG CAPSULE 100S, a neurological medication. It has an ultimate completion date of June 24, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,407.59 firm fixed-price contract is for the delivery of VYVANSE 70 MG CAPSULE 100S, a prescription medication. The award is not associated with a set-aside program and has an ultimate completion date of May 22, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,123.75 firm fixed-price contract is for the supply of VYVANSE 70 MG CAPSULE 100S, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 21, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a $4,022.73 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product. The contract is set to expire on September 16, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military...